The genetic damage which accompanies the development and progression of breast cancer has been linked to defects in the DNA synthetic and DNA repair processes of these cells; and these defects correlate with changes in the physical structure and enzymatic activity of several proteins used to carry-out DNA synthesis and repair. The investigator's data indicate that, as compared to normal breast cells, breast cancer cells exhibit a 3-4-fold higher DNA synthetic rate, a 6-8-fold decrease in replication fidelity, and have specific structural alterations in several of the proteins used to carry-out DNA replication. His goal, therefore, is to establish a clear link between the differences in the DNA synthetic activity and replication fidelity of normal and malignant breast cells and the structural changes specific replication essential proteins undergo during transformation. To accomplish this, he will initially focus on defining the kinetic, biophysical, and detailed structural properties of the DNA polymerases and poly(ADP-ribose) polymerase (PARP) by determining: 1) differences in the kinetic properties of these enzymes between the normal and malignant breast cells looking specifically at the Km and Vmax for substrate utilization, substrate specificity, and the proof-reading activity of the intrinsic 3-5' exonuclease of DNA polymerases delta and epsilon; as well as the fidelity with which all of the DNA polymerases carry-out DNA synthesis; 2) differences in the biophysical characteristics of normal and malignant breast cell DNA polymerases alpha, delta, epsilon and PARP looking specifically at the molecular weight, Stokes radii, sedimentation coefficient, isoelectric point, and 2D-PAGE profiles of these enzymes; and 3) differences in the 2D-PAGE tryptic peptide maps of the normal and malignant breast cell polymerases looking specifically at the role of phosphorylation, poly(ADP-ribosylation), and primary amino acid sequence in mediating these differences.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA074904-01
Application #
2372121
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Spalholz, Barbara A
Project Start
1997-12-18
Project End
2000-11-30
Budget Start
1997-12-18
Budget End
1998-11-30
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Pharmacology
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Wang, C (2012) Childhood rhabdomyosarcoma: recent advances and prospective views. J Dent Res 91:341-50
Zhang, Y; Wang, C (2011) Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR transcription target that promotes survival and motility in alveolar rhabdomyosarcoma cells. Oncogene 30:3549-62
Dai, Heqiao; Liu, Jianying; Malkas, Linda H et al. (2009) Characterization of RNA primers synthesized by the human breast cancer cell DNA synthesome. J Cell Biochem 106:798-811
Dai, Heqiao; Liu, Jianying; Malkas, Linda H et al. (2009) Chromium reduces the in vitro activity and fidelity of DNA replication mediated by the human cell DNA synthesome. Toxicol Appl Pharmacol 236:154-65
Yang, Jin; Chen, Zhiwen; Liu, Yang et al. (2004) Altered DNA polymerase iota expression in breast cancer cells leads to a reduction in DNA replication fidelity and a higher rate of mutagenesis. Cancer Res 64:5597-607
Abdel-Aziz, Waleed; Hickey, Robert J; Malkas, Linda H (2004) An in vitro model system that can differentiate the stages of DNA replication affected by anticancer agents. Biochem Pharmacol 68:11-21
Abdel-Aziz, Waleed; Malkas, Linda H; Wills, Philip W et al. (2003) The DNA synthesome: its potential as a novel in vitro model system for studying S-phase specific anticancer agents. Crit Rev Oncol Hematol 48:19-33
da Silva, Alcides J M; Buarque, Camilla D; Brito, Flavia V et al. (2002) Synthesis and preliminary pharmacological evaluation of new (+/-) 1,4-naphthoquinones structurally related to lapachol. Bioorg Med Chem 10:2731-8
Vertino, Paula M; Sekowski, Jennifer A; Coll, Jennifer M et al. (2002) DNMT1 is a component of a multiprotein DNA replication complex. Cell Cycle 1:416-23
Abdel-Aziz, W; Jiang, H Y; Hickey, R J et al. (2000) Ara-C affects formation of cancer cell DNA synthesome replication intermediates. Cancer Chemother Pharmacol 45:312-9

Showing the most recent 10 out of 13 publications